China NT Pharma Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2114L1059
HKD
0.80
-0.04 (-4.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -45.42% and Operating profit at 13.98% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Flat results in Jun 25

3

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 479 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.13

stock-summary
Return on Equity

20.16%

stock-summary
Price to Book

-1.58

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.23%
0%
-25.23%
6 Months
75.82%
0%
75.82%
1 Year
175.86%
0%
175.86%
2 Years
12.68%
0%
12.68%
3 Years
-17.53%
0%
-17.53%
4 Years
1011.11%
0%
1011.11%
5 Years
684.31%
0%
684.31%

China NT Pharma Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-45.42%
EBIT Growth (5y)
13.98%
EBIT to Interest (avg)
-0.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
1.30
Tax Ratio
0.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
96.23%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.80
EV to EBIT
-68.60
EV to EBITDA
-71.37
EV to Capital Employed
23.26
EV to Sales
44.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.90%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by China NT Pharma Group Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -96.64% vs -11.86% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 52.07% vs 57.68% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.10",
          "val2": "240.80",
          "chgp": "-96.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-60.80",
          "val2": "33.30",
          "chgp": "-282.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "31.80",
          "val2": "83.40",
          "chgp": "-61.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.30",
          "val2": "-0.40",
          "chgp": "675.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-37.00",
          "val2": "-77.20",
          "chgp": "52.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7,630.70%",
          "val2": "36.70%",
          "chgp": "-766.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
8.10
240.80
-96.64%
Operating Profit (PBDIT) excl Other Income
-60.80
33.30
-282.58%
Interest
31.80
83.40
-61.87%
Exceptional Items
2.30
-0.40
675.00%
Consolidate Net Profit
-37.00
-77.20
52.07%
Operating Profit Margin (Excl OI)
-7,630.70%
36.70%
-766.74%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -96.64% vs -11.86% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 52.07% vs 57.68% in Dec 2022

stock-summaryCompany CV
About China NT Pharma Group Co., Ltd. stock-summary
stock-summary
China NT Pharma Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available